↓ Skip to main content

Apelin-13 Suppresses Neuroinflammation Against Cognitive Deficit in a Streptozotocin-Induced Rat Model of Alzheimer’s Disease Through Activation of BDNF-TrkB Signaling Pathway

Overview of attention for article published in Frontiers in Pharmacology, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
112 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Apelin-13 Suppresses Neuroinflammation Against Cognitive Deficit in a Streptozotocin-Induced Rat Model of Alzheimer’s Disease Through Activation of BDNF-TrkB Signaling Pathway
Published in
Frontiers in Pharmacology, April 2019
DOI 10.3389/fphar.2019.00395
Pubmed ID
Authors

Huaiqing Luo, Yang Xiang, Xiangping Qu, Huijun Liu, Chi Liu, Guangyi Li, Li Han, Xiaoqun Qin

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 22 23%
Researcher 12 13%
Student > Master 10 10%
Student > Bachelor 6 6%
Student > Doctoral Student 6 6%
Other 11 11%
Unknown 29 30%
Readers by discipline Count As %
Neuroscience 27 28%
Medicine and Dentistry 9 9%
Agricultural and Biological Sciences 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Biochemistry, Genetics and Molecular Biology 4 4%
Other 9 9%
Unknown 34 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2019.
All research outputs
#4,254,097
of 23,146,350 outputs
Outputs from Frontiers in Pharmacology
#1,874
of 16,540 outputs
Outputs of similar age
#81,328
of 319,133 outputs
Outputs of similar age from Frontiers in Pharmacology
#84
of 369 outputs
Altmetric has tracked 23,146,350 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,540 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,133 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 369 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.